References
- Barrett, J.C., Fry, B., Maller, J., and Daly, M.J. (2005). Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263-265 https://doi.org/10.1093/bioinformatics/bth457
- Dunn, E.J., and Ariens, R.A. (2004). Fibrinogen and fibrin clot structure in diabetes. Herz 29, 470-479 https://doi.org/10.1007/s00059-004-2607-z
- Engstrom, G., Hedblad, B., Janzon, L., and Lindgarde, F. (2007). Long-term change in cholesterol in relation to inflammation- sensitive plasma proteins: a longitudinal study. Ann. Epidemiol. 17, 57-63 https://doi.org/10.1016/j.annepidem.2006.03.005
- Ernst, E., and Resch, K.L. (1993). Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann. Intern. Med. 118, 956-963 https://doi.org/10.7326/0003-4819-118-12-199306150-00008
- Festa, A., D'Agostino, R.J., Tracy, R.P., and Haffner, S.M. (2002). Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes 51, 1131-1137 https://doi.org/10.2337/diabetes.51.4.1131
- Friedlander, Y., Kark, J.D., Sinnreich, R., Basso, F., and Humphries, S.E. (2003). Combined segregation and linkage analysis of fibrinogen variability in Israeli families: evidence for two quantitative-trait loci, one of which is linked to a functional variant (-58G > A) in the promoter of the alpha-fibrinogen gene. Ann. Hum. Genet. 67, 228-241 https://doi.org/10.1046/j.1469-1809.2003.00016.x
- Ganda, O.P., and Arkin, C.F. (1992). Hyperfibrinogenemia. An important risk factor for vascular complications in diabetes. Diabetes Care 15, 1245-1250 https://doi.org/10.2337/diacare.15.10.1245
- Grimble, R.F. (2002). Infammatory status and insulin resistance. Curr. Opin. Clin. Nutr. Metab. Care 5, 551-559 https://doi.org/10.1097/00075197-200209000-00015
- Hamsten, A., Iselius, L., de Faire, U., and Blomback, M. (1987). Genetic and cultural inheritance of plasma fibrinogen concentration. Lancet. 2, 988-991 https://doi.org/10.1016/S0140-6736(87)92557-8
- Heinrich, J., Funke, H., Rust, S., Schulte, H., Schonfeld, R., and Kohler, E. (1995). Impact of polymorphisms in the alpha- and beta-fibrinogen gene on plasma fibrinogen concentrations of coronary heart disease patients. Thromb. Res. 77, 209-215 https://doi.org/10.1016/0049-3848(95)91608-N
- Hotamisligil, G.S., and Spiegelman, B.M. (1994). Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes 43, 1271-1278 https://doi.org/10.2337/diabetes.43.11.1271
- Hotamisligil, G.S., Shargill, N.S., and Spiegelman, B.M. (1993). Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259, 87-91 https://doi.org/10.1126/science.7678183
- Hsueh, W.A., Lyon, C.J., and Quinones, M.J. (2004). Insulin resistance and the endothelium. Am. J. Med. 117, 109-117 https://doi.org/10.1016/j.amjmed.2004.02.042
- Hurd, C.O., Cheetham-Wilkinson, C., and Ouwehand, W. (2000). HPA-1, -2 and -3 genotyping using the Taqman?reaction. Transfus. Med. 10, 326
- Imperatore, G., Riccardi, G., Iovine, C., Rivellese, A.A., and Vaccaro, O. (1998). Plasma fibrinogen: a new factor of the metabolic syndrome. A population-based study. Diabetes Care 21, 649-654 https://doi.org/10.2337/diacare.21.4.649
- Jonsson, A., and Wales, J.K. (1976). Blood glycoprotein levels in diabetes mellitus. Diabetologia 12, 245-250 https://doi.org/10.1007/BF00422091
- Kamath, S., and Lip, G.Y. (2003). Fibrinogen: biochemistry, epidemiology and determinants. Qjm 96, 711-729 https://doi.org/10.1093/qjmed/hcg129
- Kannel, W.B., D'Agostino, R.B., Wilson, P.W., Belanger, A.J., and Gagnon, D.R. (1990). Diabetes, fibrinogen, and risk of cardiovascular disease: the Framingham experience. Am. Heart J. 120, 672-676 https://doi.org/10.1016/0002-8703(90)90026-T
- Landin, K., Tengborn, L., and Smith, U. (1990). Elevated fibrinogen and plasminogen activator inhibitor (PAI-1) in hypertension are related to metabolic risk factors for cardiovascular disease. J. Intern. Med. 227, 273-278 https://doi.org/10.1111/j.1365-2796.1990.tb00157.x
- Manolio, T.A., Cushman, M., Gottdiener, J.S., Dobs, A., Kuller, L.H., and Kronmal, R.A. (2004). Predictors of falling cholesterol levels in older adults: the Cardiovascular Health Study. Ann. Epidemiol. 14, 325-331 https://doi.org/10.1016/j.annepidem.2003.09.006
- Maumus, S., Marie, B., Vincent-Viry, M., Siest, G., and Visvikis-Siest, S. (2007). Analysis of the effect of multiple genetic variants of cardiovascular disease risk on insulin concentration variability in healthy adults of the STANISLAS cohort. The role of FGB -455 G/A polymorphism. Atherosclerosis 191, 369-376 https://doi.org/10.1016/j.atherosclerosis.2006.04.003
- McMillan, D.E. (1989). Increased levels of acute-phase serum proteins in diabetes. Metabolism 38, 1042-1046 https://doi.org/10.1016/0026-0495(89)90038-3
- Mosesson, M.W., Siebenlist, K.R., and Meh, D.A. (2001). The structure and biological features of fibrinogen and fibrin. Ann. N. Y. Acad. Sci. 936, 11-30 https://doi.org/10.1111/j.1749-6632.2001.tb03491.x
- Nickerson, D.A., Tobe, V.O., and Taylor, S.L. (1997). Poly-Phred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing. Nucleic Acids Res. 25, 2745-275 https://doi.org/10.1093/nar/25.14.2745
- Pauline, C., Ng, P.C., and Henikoff, S. (2002). Accounting for human polymorphisms predicted to affect protein function. Genome Res. 12, 436-446 https://doi.org/10.1101/gr.212802
- Pickup, J.C. (2006). Inflammatory markers and type 2 diabetes. Diabetes Technol. Ther. 8, 1-6 https://doi.org/10.1089/dia.2006.8.1
- Pickup, J.C., and Crook, M.A. (1998). Is type II diabetes mellitus a disease of the innate immune system? Diabetologia 41, 1241-1248 https://doi.org/10.1007/s001250051058
- Ramensky, V., Bork, P., and Sunyaev, S. (2002). Human non-synonymous SNPs: server and survey. Nucleic Acids Res. 30, 3894-3900 https://doi.org/10.1093/nar/gkf493
- Redman, C.M., and Xia, H. (2001). Fibrinogen biosynthesis. Assembly, intracellular degradation, and association with lipid synthesis and secretion. Ann. N. Y. Acad. Sci. 936, 480-495 https://doi.org/10.1111/j.1749-6632.2001.tb03535.x
- Roy, S., Overton, O., and Redman, C. (1994). Overexpression of any fibrinogen chain by Hep G2 cells specifically elevates the expression of the other two chains. J. Biol. Chem. 269, 691-695
- Rozen, S., and Skaletsky, H. (2000). Primer3 on the WWW for general users and for biologist programmers. Methods Mol. Biol. 132, 365-386 https://doi.org/10.1385/1592591922
- Sakkinen, P.A., Wahl, P., Cushman, M., Lewis, M.R., and Tracy, R.P. (2000). Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome. Am. J. Epidemiol. 152, 897-907 https://doi.org/10.1093/aje/152.10.897
- Spranger, J., Kroke, A., Mohlig, M., Hoffmann, K., Bergmann, M.M., and Ristow, M. (2003). Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes. Technol. Ther. 52, 812-817 https://doi.org/10.2337/diabetes.52.3.812
- Xu, H., Barnes, G.T., Yang, Q., Tan, G., Yang, D., Chou, C.J., Sole, J., Nichols, A., Ross, J.S., Tartaglia, L.A., et al. (2003). Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112, 1821-1830 https://doi.org/10.1172/JCI19451